Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial

References

• Weinberg RS, Peyman GA, Huamonte FU. Elevation of intraocular pressure after pars plana vitrectomy. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976;200(2):157–161. doi:10.1007/BF004143651086606
   PubMedGoogle Scholar
• Faulbom J, Conway BP, Machemer R. Surgical complications of pars plana vitreous surgery. Ophthalmology. 1978;85(2):116–125. doi:10.1016/S0161-6420(78)35684-0643250
   PubMed Web of Science ®Google Scholar
• Antoun J, Azar G, Jabbour E, et al. Vitreoretinal surgery with silicone oil tamponade in primary uncomplicated rhegmatogenous retinal detachment. Retina. 2016;36(10):1906–1912. doi:10.1097/IAE.000000000000100826966864
   PubMed Web of Science ®Google Scholar
• Jonas JB, Knorr HL, Rank RM, Budde WM. Intraocular pressure and silicone oil endotamponade. J Glaucoma. 2001;10(2):102–108. doi:10.1097/00061198-200104000-0000611316091
   PubMed Web of Science ®Google Scholar
• Fang Y, Long Q, Wang X, Jiang R, Sun X. Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension. Clin Ophthalmol. 2017;11:2091–2097. eCollection 2017. doi:10.2147/OPTH.S14498529200822
   PubMed Web of Science ®Google Scholar
• Al-Jazzaf AM, Netland PA, Charles S. Incidence and management of elevated intraocular pressure after silicone oil injection. J Glaucoma. 2005;14(1):40–46.15650603
   PubMed Web of Science ®Google Scholar
• Mangouritsas G, Mourtzoukos S, Portaliou DM, Georgopoulos VI, Dimopoulou A, Feretis E. Glaucoma associated with the management of rhegmatogenous retinal detachment. Clin Ophthalmol. 2013;7:727–734. doi:10.2147/OPTH.S4279223620656
   PubMedGoogle Scholar
• Hathout RM, Gad HA, Abdel-Hafez SM, et al. Gelatinized core liposomes: a new Trojan horse for the development of a novel timolol maleate glaucoma medication. Int J Pharm. 2019;556:192–199. doi:10.1016/j.ijpharm.2018.12.01530553005
   PubMed Web of Science ®Google Scholar
• Shokry M, Hathout RM, Mansour S. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: augmented in-vivo efficacy and safe histological profile. Int J Pharm. 2018;545(1–2):229–239. doi:10.1016/j.ijpharm.2018.04.05929709617
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Primary Open-Angle Glaucoma Preferred Practice Patterns. San Francisco: American Academy of Ophthalmology; 2010 Available from: http://one.aao.org/preferred-practice-pattern/primary-openangle-glaucoma-ppp-october-2010.
   Google Scholar
• Li T, Lindsley K, Rouse B, et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology. 2016;123(1):129–140. doi:10.1016/j.ophtha.2015.09.00526526633
   PubMed Web of Science ®Google Scholar
• Fechtner RD, Khouri AS, Zimmerman TJ, et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol. 1998;126:37–41. doi:10.1016/S0002-9394(98)00071-39683147
   PubMed Web of Science ®Google Scholar
• Ornek K, Onaran Z, Turgut Y. Anterior uveitis associated with fixed-combination latanoprost and timolol. Can J Ophthalmol. 2008;43:727–728. doi:10.3129/i08-11319020649
   PubMed Web of Science ®Google Scholar
• Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand. 1999;77:668–672. doi:10.1034/j.1600-0420.1999.770612.x10634560
   PubMedGoogle Scholar
• Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology. 1998;105:263–268. doi:10.1016/S0161-6420(98)92977-39479285
   PubMed Web of Science ®Google Scholar
• Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. Am J Ophthalmol. 1999;127:602. doi:10.1016/S0002-9394(99)00050-110334356
   PubMed Web of Science ®Google Scholar
• Kroll DM, Schuman JS. Reactivation of herpes simplex viruskeratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol. 2002;133:401–403. doi:10.1016/S0002-9394(01)01360-511860979
   PubMed Web of Science ®Google Scholar
• Gordon YJ, Yates KA, Mah FS, Romanowski EG. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models. J Ocul Pharmacol Ther. 2003;19(3):233–245. doi:10.1089/10807680332190835612828841
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2009;247(6):775–780. doi:10.1007/s00417-009-1036-319184081
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Kanda T, Taguchi M, Shibata M, Mine I, Sakurai Y. Evaluation of efficacy and safety of latanoprost/timolol versus travoprost/timolol fixed combinations for ocular hypertension associated with uveitis. Ocul Immunol Inflamm. 2017;25(1):105–110. doi:10.3109/09273948.2015.109255926799307
   PubMed Web of Science ®Google Scholar
• Fortuna E, Cervantes-Castañeda RA, Bhat P, Doctor P, Foster CS. Flare-up rates with bimatoprost therapy in uveitic glaucoma. Am J Ophthalmol. 2008;146(6):876–882. doi:10.1016/j.ajo.2008.08.02219027422
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey P, Missotten T, Ferrante P, Jalaludin B, Lightman S. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol. 2008;92(7):916–921. doi:10.1136/bjo.2007.13103718460537
   PubMed Web of Science ®Google Scholar
• Fang Y, Ku H, Liu Y, Gan D. Trends in the characteristics of vitrectomy in Eastern China. Clin Ophthalmol. 2018;12:1993–2000. doi:10.2147/OPTH.S17325130349182
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471. doi:10.1016/S0161-6420(85)34001-04000641
   PubMed Web of Science ®Google Scholar
• Koreen L, Yoshida N, Escariao P, Niziol LM, Koreen IV, Musch DC. Incidence of, risk factors for, and combined mechanism of late-onset open-angle glaucoma after vitrectomy. Retina. 2012;32(1):160–167. doi:10.1097/IAE.0b013e318217fffb21765372
   PubMed Web of Science ®Google Scholar
• Muether PS, Hoerster R, Kirchhof B, Fauser S. Course of intraocular pressure after vitreoretinal surgery: is early postoperative intraocular pressure elevation predictable? Retina. 2011;31(8):1545–1552. doi:10.1097/IAE.0b013e31820f4b0521610561
   PubMed Web of Science ®Google Scholar
• Gupta D, Chen PP. Glaucoma. Am Fam Physician. 2016;93(8):668–674.27175839
   PubMed Web of Science ®Google Scholar
• Netland PA, Landry T, Sullivan EK, et al., Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132(4):472–484. doi:10.1016/s0002-9394(01)01177-1.11589866
   PubMed Web of Science ®Google Scholar
• Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology. 1996;103(1):126–137. doi:10.1016/s0161-6420(96)30750-18628543
   PubMed Web of Science ®Google Scholar
• Li F, Huang W, Zhang X. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis. Acta Ophthalmol. 2018;96(3):e277–e284. doi:10.1111/aos.1356829144028
   PubMed Web of Science ®Google Scholar
• Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmol. 2008;53 Suppl1:S93–S105. doi:10.1016/j.survophthal.2008.08.00419038628
   PubMed Web of Science ®Google Scholar
• Astin M, Stjernschantz J, Sele´n G. Role of nitric oxide in PGF2 alpha-induced ocular hyperemia. Exp Eye Res. 1994;59:401–407. doi:10.1006/exer.1994.11247532135
   PubMed Web of Science ®Google Scholar